Target
ectodomain vimentin (EDV)
1 abstract
Abstract
Phase 1 study of pritumumab in brain cancer.Org: Pacific Neuroscience Institute and Saint John’s Cancer Institute at Providence Saint John’s Health Center, Saint John's Cancer Institute at Providence Saint John's Health Center, Nascent Biotech, Inc., Sharp HealthCare, Gilman Biosciences,